Clinical Efficacy of Calcium Gluconate Combined With Ergometrine Maleate in the Prevention of Uterine Atony‐Induced Postpartum Hemorrhage and Their Effects on Coagulation Function

This study aims to explore the clinical efficacy of calcium gluconate combined with ergometrine maleate in preventing and treating uterine atony-induced postpartum hemorrhage (PPH) and its impacts on coagulation function. Ninety-six postpartum women with uterine atony were randomly assigned into a study group and a control group (48 cases each) using a double-blind method. The control group received calcium gluconate, while the study group received calcium gluconate combined with ergometrine maleate. Postpartum blood loss at 2 and 24 h, hemostasis time, hemoglobin levels, red blood cell (RBC) count, coagulation indices (PT, TT, APTT, D-D, FIB), inflammatory markers (CRP, IL-6, PCT), labor duration, hospital stay, menstruation recovery, stress-related indicators, and blood viscosity were compared. The study group had significantly lower postpartum blood loss, shorter labor stages, and higher hemoglobin levels and RBC counts at 24 h (p < 0.05). Postpartum, PT, TT, APTT, D-D, inflammatory markers, and stress indicators were lower, while FIB was higher in the study group (p < 0.05). The combination of ergometrine maleate and calcium gluconate effectively reduces PPH, improves stress-related inflammation, and shortens hemostasis time, demonstrating significant clinical benefits.